Join our daily newsletter At The Bell to receive exclusive market insights
- Medical imaging software specialist Mach7 Technologies (M7T) has appointed Philippe Houssiau as the company’s newest Non-Executive Director
- Philippe has previously worked at Agfa Healthcare, Alliance Healthcare, Hg Private Equity, Orion Health and Price Waterhouse
- He’s currently based in Belgium and will take on the new Non-Executive Director role within Mach7 from January 1, 2021
- The company said it decided to appoint a new director after a transformational 2020 which saw the business grow rapidly
- Shares in Mach7 are trading up 2.93 per cent at $1.23 each
Mach7 Technologies (M7T) has appointed Philippe Houssiau as the company’s newest Non-Executive Director.
The medical imaging software specialist announced the new appointment in a market release to shareholders on Tuesday.
The new director will bring years of experience to the role, having worked in a variety of executive and board member roles for health and IT companies across the globe.
These include a stint as CEO for Agfa Healthcare and Alliance Healthcare, as well as a Partner position with Hg Private Equity, Chairman of Orion Health and Senior Manager at Price Waterhouse.
Commenting on the appointment, Mach7 Technologies Chairman David Chambers said the company decided to appoint a new director after 2020 proved to be a “transformational year” in which the business grew rapidly.
“We are extremely pleased to welcome a person of Philippe’s standing in the global Healthcare IT community to the Mach7 Board,” David said.
“Philippe’s expertise, drawn from broad experience as a CEO and Chairman
of Healthcare related companies, particularly within the global Diagnostic Imaging market, will prove to be invaluable,” he added.
The director is currently based in Antwerp, Belgium and Mach7 stated Philippe will assume his new role within the company from January 1, 2021.
Following the appointment, shares in M7T are up 2.93 per cent at $1.23 each at 2:03 pm AEDT.
